Resources from the same session
Clinical Development of KRAS G12C Inhibitors – Where Are We Now?
Presenter: P. Janne, US
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Moving Forward with KRAS G12C Inhibitors – Combinations, Sequencing, Early stage
Presenter: C. Lindsay, UK
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Clinical Cases and Expert Panel Discussion: Single Agent Case with Liver Toxicity
Presenter: G. Pasello, IT
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast
Clinical Cases and Expert Panel Discussion: Combination Therapy
Presenter: C. Bestvina, US
Session: Session 2 – Targeting KRAS G12C in Lung Cancer
Resources:
Slides
Webcast